Targeting NLRP3 signaling pathway to inhibit brain inflammation could be effective for treating ADRD and neurodegenerative diseases Although some NLRP3 inhibitors have been tested in clinical trials for inflammatory diseases, none have been successful in treating ADRD. This evidence concerns the gene NLRP3 and neurodegenerative disease.